Paxman AB (publ) Share Price Nasdaq Stockholm
Equities
SE0009806284
Medical Equipment, Supplies & Distribution
Sales 2023 | 21Cr 2.01Cr 167.65Cr | Sales 2024 * | 29Cr 2.79Cr 232.98Cr | Capitalization | 90Cr 8.65Cr 722.08Cr |
---|---|---|---|---|---|
Net income 2023 | 80L 8L 6.38Cr | Net income 2024 * | 3.4Cr 32.51L 27Cr | EV / Sales 2023 | 3.33 x |
Net cash position 2023 * | 1.9Cr 18.17L 15Cr | Net cash position 2024 * | 4.2Cr 40.16L 34Cr | EV / Sales 2024 * | 2.96 x |
P/E ratio 2023 |
83.6
x | P/E ratio 2024 * |
26.4
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 36.29% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Paxman
CEO | Chief Executive Officer | 41 | 20/16/20 |
Director of Finance/CFO | 44 | 01/20/01 | |
Patrick Burke
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/09/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Björn Littorin
BRD | Director/Board Member | 77 | 01/16/01 |
Chairman | 70 | 01/16/01 | |
Maria Bech
BRD | Director/Board Member | 56 | 20/16/20 |
1st Jan change | Capi. | |
---|---|---|
-6.54% | 18TCr | |
-0.32% | 11TCr | |
-2.05% | 6.9TCr | |
-7.14% | 4.58TCr | |
+12.24% | 4.54TCr | |
+8.60% | 4.32TCr | |
+15.37% | 2.99TCr | |
+13.65% | 2.55TCr | |
-6.64% | 2.39TCr |